Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28326 - 28350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	CCDC102A	92922	downregulated	Cytarabine results in decreased expression of CCDC102A mRNA	16q21	A21886
Cytarabine	Approved Investigational	CCDC112	153733	upregulated	Cytarabine results in increased expression of CCDC112 mRNA	5q22.3	A21886
Cytarabine	Approved Investigational	CCDC15	80071	upregulated	Cytarabine results in increased expression of CCDC15 mRNA	11q24.2	A21886
Cytarabine	Approved Investigational	CCKBR	887	downregulated	Cytarabine results in decreased expression of CCKBR mRNA	11p15.4	A21886
Cytarabine	Approved Investigational	CCND3	896	downregulated	Cytarabine results in decreased expression of CCND3 mRNA	6p21.1	A21886
Cytarabine	Approved Investigational	CCNE2	9134	upregulated	Cytarabine results in increased expression of CCNE2 mRNA	8q22.1	A21886
Cytarabine	Approved Investigational	CD44	960	downregulated	Cytarabine results in decreased expression of CD44 mRNA	11p13	A21886
Cytarabine	Approved Investigational	CD8A	925	upregulated	Cytarabine results in increased expression of CD8A mRNA	2p11.2	A20985
Cytarabine	Approved Investigational	CDC42EP5	148170	downregulated	Cytarabine results in decreased expression of CDC42EP5 mRNA	19q13.42	A21886
Cytarabine	Approved Investigational	CDCA8	55143	downregulated	Cytarabine results in decreased expression of CDCA8 mRNA	1p34.3	A20666
Cytarabine	Approved Investigational	CDH11	1009	downregulated	Cytarabine results in decreased expression of CDH11 mRNA	16q21	A21886
Cytarabine	Approved Investigational	CDH3	1001	downregulated	Cytarabine results in decreased expression of CDH3 mRNA	16q22.1	A21886
Cytarabine	Approved Investigational	CDKN1C	1028	downregulated	Cytarabine results in decreased expression of CDKN1C mRNA	11p15.4	A21886
Cytarabine	Approved Investigational	CEBPD	1052	downregulated	Cytarabine results in decreased expression of CEBPD mRNA	8q11.21	A21886
Cytarabine	Approved Investigational	CELF3	11189	upregulated	Cytarabine results in increased expression of CELF3 mRNA	1q21.3	A21886
Cytarabine	Approved Investigational	CEMIP	57214	downregulated	Cytarabine results in decreased expression of CEMIP mRNA	15q25.1	A21886
Cytarabine	Approved Investigational	CHN1	1123	downregulated	Cytarabine results in decreased expression of CHN1 mRNA	2q31.1	A21886
Cytarabine	Approved Investigational	CITED2	10370	downregulated	Cytarabine results in decreased expression of CITED2 mRNA	6q24.1	A21886
Cytarabine	Approved Investigational	CKB	1152	upregulated	Cytarabine results in increased expression of CKB mRNA	14q32.33	A21886
Cytarabine	Approved Investigational	CKS2	1164	downregulated	Cytarabine results in decreased expression of CKS2 mRNA	9q22.2	A20666
Cytarabine	Approved Investigational	CLDN15	24146	downregulated	Cytarabine results in decreased expression of CLDN15 mRNA	7q22.1	A21886
Cytarabine	Approved Investigational	CLEC1B	51266	downregulated	Cytarabine results in decreased expression of CLEC1B mRNA	12p13.31-p13.2	A21886
Cytarabine	Approved Investigational	CNIH2	254263	upregulated	Cytarabine results in increased expression of CNIH2 mRNA	11q13.2	A21886
Cytarabine	Approved Investigational	CNR1	1268	upregulated	Cytarabine results in increased expression of CNR1 mRNA	6q15	A21886
Cytarabine	Approved Investigational	CNTFR	1271	upregulated	Cytarabine results in increased expression of CNTFR mRNA	9p13.3	A21886

Displaying entries 28326 - 28350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability